Fig. 1
From: A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2
SHOX2 expression levels in normal tissues and tumors including glioma. A The differences of SHOX2 expression levels in 27 tumor tissues and normal tissues in TCGA combined with GTEx database by SangerBox. B The correlation between SHOX2 expression and glioma WHO grade (II, II and IV) in TCGA, CGGA and GSE16011 datasets. The expression level of SHOX2 in different IDH status (C) and 1p/19q status (D) of gliomas in TCGA, CGGA and GSE16011 datasets. E The expression level of SHOX2 in different MGMT promotor status of gliomas in TCGA database. F The correlation between SHOX2 expression and glioma three types (oligodendroglioma, astrocytoma and glioblastoma) in TCGA database. **P < 0.01, ***P < 0.001, ****P < 0.0001